This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Myeloproliferative disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Myeloproliferative disorders are a heterogenous group of disorders which result from clonal neoplastic proliferation of one or more myeloid stem cells. Each disorder produces a characteristic syndrome with well-defined clinical and laboratory features but they are grouped together since one disease may evolve into another and all may progress to acute myeloid leukaemia.

Specific types are named according to the predominant differentiation pathway followed:

  • chronic myeloid (granulocytic) leukaemia - myeloid differentiation
  • polycythaemia vera - erythroid differentiation
  • essential thrombocythaemia - platelet differentiation
  • myeloid metaplasia with myelofibrosis - multilineage differentiation with marrow fibrosis

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.